These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
|
CA
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Title of each class
|
Trading
Symbol
|
Name of each exchange
on which registered
|
||
|
|
|
|
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
|
|
☒ | Smaller reporting company |
|
|||
| Emerging growth company |
|
|||||
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2025
TABLE OF CONTENTS
i
|
Assets:
|
||||
|
Current assets
|
||||
|
Cash
|
$ |
|
||
|
Due from Sponsor
|
|
|||
|
Prepaid expenses
|
|
|||
|
|
|
|||
|
Total current assets
|
|
|||
|
Long Term prepaid insurance
|
|
|||
|
Marketable securities held in Trust Account
|
|
|||
|
|
|
|||
|
Total Assets
|
$
|
|
|
|
|
|
|
|||
|
Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit
|
||||
|
Current liabilities
|
||||
|
Accrued expenses
|
$ |
|
||
|
Accrued offering costs
|
|
|||
|
Promissory note - related party
|
|
|||
|
|
|
|||
|
Total current liabilities
|
|
|||
|
Advisory Fee Payable
|
|
|||
|
Deferred underwriting fee payable
|
|
|||
|
|
|
|||
|
Total Liabilities
|
|
|
|
|
|
|
|
|||
|
Commitments and Contingencies
|
|
|||
|
Class A ordinary shares subject to possible redemption, $
|
|
|||
|
Shareholders’ Deficit
|
||||
|
Preference shares, $
|
|
|||
|
Class A ordinary shares, $
|
|
|||
|
Class B ordinary shares, $
(1)(2)
|
|
|||
|
Additional
paid-in
capital
|
|
|||
|
Accumulated deficit
|
(
|
) | ||
|
|
|
|||
|
Total Shareholders’ Deficit
|
|
(
|
)
|
|
|
|
|
|||
|
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit
|
$
|
|
|
|
|
|
|
| (1) |
On September 25, 2025, the Company issued an additional
|
| (2) |
Includes
|
|
For the Period
from July 11, 2025 (Inception) Through September 30, 2025 |
||||
|
Advisory fee expense
|
$ |
|
||
|
General and administrative expenses
|
|
|||
|
|
|
|||
|
Loss from operations
|
|
(
|
)
|
|
|
|
|
|||
|
Other income:
|
||||
|
Interest earned on marketable securities held in Trust Account
|
|
|||
|
|
|
|||
|
Total Other income
|
|
|
|
|
|
|
|
|||
|
Net loss
|
$
|
(
|
)
|
|
|
|
|
|||
|
Weighted average shares outstanding of Class A ordinary shares, basic and diluted
|
|
|||
|
|
|
|||
|
Basic and diluted net loss per ordinary share, Class A ordinary shares
|
$
|
(
|
)
|
|
|
|
|
|||
|
Weighted average shares outstanding of Class B ordinary shares, basic and diluted
(1)(2)
|
|
|||
|
|
|
|||
|
Basic net loss per ordinary share, Class B ordinary shares
|
$
|
(
|
)
|
|
|
|
|
|||
| (1) |
On September 25, 2025, the Company issued an additional
|
| (2) |
Includes
|
|
Class A
Ordinary Shares |
Class B
Ordinary Shares |
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Total
Shareholders’
Deficit
|
||||||||||||||||||||||||
|
Shares
|
Amount
|
Shares
(1)(2)
|
Amount
|
|||||||||||||||||||||||||
|
Balance — July 11, 2025 (Inception)
|
|
$ |
|
— | $ | — | $ | — | $ | — | $ | — | ||||||||||||||||
|
Issuance of Class B ordinary shares to Sponsor
|
— | — |
|
|
|
— |
|
|||||||||||||||||||||
|
Accretion for Class A ordinary shares to redemption amount
|
— | — | — | — |
(
|
) |
(
|
) |
(
|
) | ||||||||||||||||||
|
Sale of
|
|
|
— | — |
|
— |
|
|||||||||||||||||||||
|
Allocated value of transaction costs to Private Placement Shares
|
— | — | — | — |
(
|
) | — |
(
|
) | |||||||||||||||||||
|
Net loss
|
— | — | — | — | — |
(
|
) |
(
|
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Balance – September 30, 2025
|
|
|
|
$
|
|
|
|
|
|
$
|
|
|
$
|
—
|
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| (1) |
On September 25, 2025, the Company issued an additional
|
| (2) |
Includes
allotment
option was not exercised in full or in part by the underwriters. Subsequently, on September 29,
2025
, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the
|
|
For the Period
from July 11, 2025 (Inception) Through September 30, 2025 |
||||
|
Cash Flows from Operating Activities:
|
||||
|
Net loss
|
$ |
(
|
) | |
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||
|
Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares
|
|
|||
|
Payment of operating costs through promissory note – related party
|
|
|||
|
Interest earned on marketable securities held in Trust Account
|
(
|
) | ||
|
Changes in operating assets and liabilities:
|
||||
|
Prepaid expenses
|
(
|
) | ||
|
Long Term prepaid insurance
|
(
|
) | ||
|
Accounts payable and accrued expenses
|
|
|||
|
Advisory fee payable
|
|
|||
|
|
|
|||
|
Net cash used in operating activities
|
|
(
|
)
|
|
|
|
|
|||
|
Cash Flows from Investing Activities:
|
||||
|
Investment of cash in Trust Account
|
(
|
) | ||
|
|
|
|||
|
Net cash used in investing activities
|
|
(
|
)
|
|
|
|
|
|||
|
Cash Flows from Financing Activities:
|
||||
|
Proceeds from sale of Shares, net of underwriting discounts paid
|
|
|||
|
Proceeds from sale of Private Shares
|
|
|||
|
Proceeds from promissory note – related party
|
|
|||
|
Due from Sponsor
|
(
|
) | ||
|
Payment of offering costs
|
(
|
) | ||
|
|
|
|||
|
Net cash provided by financing activities
|
|
|
|
|
|
|
|
|||
|
Net Change in Cash
|
|
|
|
|
|
Cash – Beginning of period
|
|
|||
|
|
|
|||
|
Cash – End of period
|
$
|
|
|
|
|
|
|
|||
|
Noncash investing and financing
activities
:
|
||||
|
Offering costs included in accrued offering costs
|
$ |
|
||
|
|
|
|||
|
Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares
|
$ |
|
||
|
|
|
|||
|
Deferred underwriting fee payable
|
$ |
|
||
|
|
|
|||
|
For the period from July 11,
2025 (Inception) Through September 30, 2025 |
||||||||
|
Class A
|
Class B
|
|||||||
|
Basic and diluted net loss per share:
|
||||||||
|
Numerator:
|
||||||||
|
Allocation of net loss, basic and diluted
|
$ |
(
|
) | $ |
(
|
) | ||
|
Denominator:
|
||||||||
|
Basic and diluted weighted-average ordinary shares outstanding
|
|
|
||||||
|
|
|
|
|
|||||
|
Basic and diluted net loss per ordinary share
|
$ |
(
|
) | $ |
(
|
) | ||
|
|
|
|
|
|||||
|
Gross proceeds
|
$ |
|
||
|
Less:
|
||||
|
Class A ordinary shares issuance cost
|
(
|
) | ||
|
Plus:
|
||||
|
Remeasurement of carrying value to redemption value
|
|
|||
|
|
|
|||
|
Class A ordinary shares subject to possible redemption, September 30, 2025
|
$ |
|
||
|
|
|
|
Level 1:
|
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
|
Level 2:
|
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
|
Level 3:
|
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. | |
| Level |
September 30,
2025 |
|||||||
|
Marketable securities held in Trust Account
|
1 | $ |
|
|||||
|
For the period
from July 11, 2025 (Inception) Through September 30, 2025 |
||||
|
General and administrative expenses
|
$ |
|
||
|
Interest earned on marketable securities held in Trust Account
|
$ |
|
||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to AMERICAN EXCEPTIONALISM ACQUISITION CORP. A References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to AEXA Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated in the Cayman Islands on July 11, 2025 formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Shares, our shares, debt or a combination of cash, shares and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from July 11, 2025 (inception) through September 30, 2025 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. Subsequent to the Initial Public Offering, we generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the period from July 11, 2025 (inception) through September 30, 2025, we had a net loss $10,423,509, which consisted of general and administrative costs of $10,461,169 offset by, Interest earned on marketable securities held in trust Account of $37,660.
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share, by the Sponsor and loans from the Sponsor.
Subsequent to the quarterly period covered by this Quarterly Report on Form 10-Q, on October 1, 2025, on September 29, 2025, we consummated the Initial Public Offering of 34,500,000 Class A Ordinary Shares which includes the full exercise by the underwriters of their over-allotment option in the amount of 4,500,000 Class A Ordinary Shares, at $10.00 per share, generating gross proceeds of $345,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 175,000 private placement shares, at a price of $10.00 per Private Placement Share in a private placement to the Sponsor, generating gross proceeds of $1,750,000.
Following the Initial Public Offering, the full exercise of the over-allotment option, and the sale of the Shares, a total of $345,000,000 was placed in the Trust Account. We incurred $11,130,322, consisting of $250,000 of cash underwriting fee, $10,350,000 of deferred underwriting fee, and $530,322 of other offering costs.
17
For the period from July 11, 2025 (inception) through September 30, 2025 , net cash used in operating activities was $320,647. This amount primarily reflects a net loss of $10,423,509, partially offset by interest income of $37,660, general and administrative costs paid through a related party promissory note of $22,830, formation costs of $8,488 paid by the Sponsor in exchange for Class B ordinary shares, and changes in operating assets and liabilities of $10,109,204.
We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such Working Capital Loans may be converted into private placement shares upon consummation of the Business Combination at a price of $10.00 per share. The shares would be identical to the Private Placement Shares.
We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2025. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement that the Company have granted the underwriter a 45-day option from the date of the Initial Public Offering to purchase up to an additional 3,450,000 Class A Ordinary Shares to cover over-allotments, if any. On September 29, 2025, the underwriters exercised their over-allotment option, closing on the 3,450,000 additional Class A Ordinary Shares simultaneously with the Initial Public Offering.
The underwriter was entitled to an underwriting discount of $250,000 which was paid in cash upon the closing of the Initial Public Offering.
The Company entered into an agreement with the underwriter in which the underwriter is entitled to an advisory fee equal to 3% of the gross proceeds raised in the Initial Public Offering upon and subject to the closing of the initial Business Combination.
Critical Accounting Estimates
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could materially differ from those estimates. As of September 30, 2025, we did not have any critical accounting estimates to be disclosed.
18
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not required for smaller reporting companies.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to Management, including our Chief Executive Officer and Chief Financial Officer (together, the “Certifying Officers”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of the end of the quarterly period ended September 30, 2025.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter of 2025 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
19
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
| * |
Filed herewith. |
| ** |
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
21
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AMERICAN EXCEPTIONALISM ACQUISITION CORP. A | ||||||
| Date: November 14, 2025 | By: | /s/ Steven Trieu | ||||
| Name: | Steven Trieu | |||||
| Title: | Chief Executive Officer | |||||
| (Principal Executive Officer) | ||||||
| Date: November 14, 2025 | By: | /s/ Jeffrey Vignos | ||||
| Name: | Jeffrey Vignos | |||||
| Title: | Chief Financial Officer | |||||
| (Principal Financial Officer and Accounting Officer) | ||||||
22
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|